The injections - called biologics - cut the number of hospitalisations and mean severe asthmatics do not have to rely on ...

Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

Following a recent decision by the NPPA, the prices of key medications for cholesterol, blood pressure, asthma, and more are ...

RAND focused its model on four chronic conditions — cardiovascular disease, asthma, end-stage kidney disease and Alzheimer’s ...

The medicines for which the prices have been increased are not very expensive to begin with and are not expected to hit ...

The National Pharmaceutical Pricing Authority (NPPA) has revised the ceiling prices of eight scheduled drugs to meet the twin ...

The company has set high expectations for depemokimab, which it is also advancing in three other inflammatory diseases, including asthma.

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...

The global airway disease treatment market is projected to experience significant growth over the next decade, with revenue ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2025, according to Statista. A large portion of that figure is from the oncology segment, which is expected ...